| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.51B | 21.73B | 18.85B | 18.61B | 14.93B | 18.67B |
| Gross Profit | 10.23B | 21.73B | 19.61B | 18.55B | 14.87B | 18.60B |
| EBITDA | 3.18B | 0.00 | 5.32B | 4.15B | 901.00M | 3.72B |
| Net Income | 2.26B | 5.01B | 3.79B | 2.92B | 778.00M | 2.83B |
Balance Sheet | ||||||
| Total Assets | 73.36B | 88.48B | 73.36B | 84.08B | 67.60B | 90.89B |
| Cash, Cash Equivalents and Short-Term Investments | 31.50B | 35.59B | 31.50B | 36.42B | 33.97B | 29.68B |
| Total Debt | 1.78B | 1.35B | 2.02B | 3.14B | 3.01B | 4.16B |
| Total Liabilities | 24.35B | 36.93B | 24.35B | 31.55B | 21.52B | 43.75B |
| Stockholders Equity | 49.01B | 51.44B | 49.01B | 52.52B | 46.09B | 47.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.06B | -1.10B | 6.99B | 10.64B | -1.14B |
| Operating Cash Flow | 0.00 | 9.29B | -160.00M | 7.56B | 10.99B | -371.00M |
| Investing Cash Flow | 0.00 | -549.00M | 509.00M | -734.00M | -4.60B | -911.00M |
| Financing Cash Flow | 0.00 | -4.89B | -5.05B | -1.89B | -1.56B | -2.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥85.73B | 6.96 | ― | 5.75% | 30.59% | 55.29% | |
75 Outperform | ¥69.64B | 12.02 | 9.22% | 6.15% | 13.26% | 31.92% | |
70 Outperform | ¥200.00B | 4.29 | ― | 4.01% | 21.03% | 85.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥233.66B | 13.77 | 14.00% | 5.13% | 34.33% | 47.34% | |
57 Neutral | ¥46.11B | 9.21 | ― | 4.86% | 10.70% | 63.03% | |
43 Neutral | ¥167.32B | 13.27 | 7.26% | 4.16% | 9.77% | -52.42% |